Literature DB >> 15645346

European validation of a standardized clinical description of multiple sclerosis.

Maria Pia Amato1, Jerome Grimaud, Iuliana Achiti, Maria Letizia Bartolozzi, Patrice Adeleine, Hans-Peter Hartung, Ludwig Kappos, Alan Thompson, Maria Trojano, Sandra Vukusic, Christian Confavreux.   

Abstract

OBJECTIVES: The EDMUS system is a clinical database specifically tailored to the description of multiple sclerosis (MS). The EVALUED (Evaluation of the EDMUS system) study is an European project with two objectives: 1) to assess the inter-examiner reliability of the whole EDMUS system; 2) to validate the EDMUS-Grading Scale (EGS),which is a simplified version of the Kurtzke Disability Status Scale (DSS).
METHODS: The protocol included 12 neurologists working in pairs within six European centres (Bari, Basel, Florence, London, Lyon, Würzburg). They assessed independently 30 MS patients in their centre, filling in the EDMUS forms. The reliability of the system was assessed on selected key items in the history of the MS onset, the clinical course and the disease course classification. The clinical examination of the patients permitted an assessment of the Kurtzke Expanded Disability Status Scale (EDSS) and the EGS. Level of agreement was measured in terms of kappa and weighted kappa indexes whenever appropriate.
RESULTS: The study included 180 patients with definite or probable MS of whom 37% were males. Age was 35.8+/-9.6 years (mean +/- SD), disease duration 7.8+/-5.7 years, and mean EDSS score 4.1+/-2.2. The disease course was relapsing-remitting in 67%, secondary progressive in 22%, and progressive from disease onset in 11%. For key items of the history, the inter-examiner reliability level ranged from moderate to excellent. Concerning the disability scales, perfect agreement was reached in 59 % for EDSS and 78% for EGS. The close correlation and linear association (r=0.94, p<0.0001) between both scales demonstrated EGS's construct validity.
CONCLUSION: The EDMUS system allows a consistent clinical description of MS using a common language. This standardized follow-up of MS patients is valuable especially in studies requiring a critical mass of informative patients.

Entities:  

Mesh:

Year:  2004        PMID: 15645346     DOI: 10.1007/s00415-004-0567-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

2.  Transitional progressive multiple sclerosis: a clinical and imaging study.

Authors:  A Gayou; B Brochet; V Dousset
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

3.  Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

Authors:  J H Noseworthy; M K Vandervoort; C J Wong; G C Ebers
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

4.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.

Authors:  B G Weinshenker; B Bass; G P Rice; J Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1989-12       Impact factor: 13.501

5.  Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis.

Authors:  M P Amato; L Fratiglioni; C Groppi; G Siracusa; L Amaducci
Journal:  Arch Neurol       Date:  1988-07

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.

Authors:  M Trojano; C Avolio; I L Simone; G Defazio; C Manzari; F De Robertis; A Calò; P Livrea
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

8.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

9.  Age-related disability in multiple sclerosis.

Authors:  Maria Trojano; Maria Liguori; Giovanni Bosco Zimatore; Roberto Bugarini; Carlo Avolio; Damiano Paolicelli; Fabrizio Giuliani; Francesca De Robertis; Maria Giovanna Marrosu; Paolo Livrea
Journal:  Ann Neurol       Date:  2002-04       Impact factor: 10.422

10.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

View more
  14 in total

1.  Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients.

Authors:  Fabrizio Salvi; Ilaria Bartolomei; Elena Buccellato; Roberto Galeotti; Paolo Zamboni
Journal:  Funct Neurol       Date:  2012 Jan-Mar

2.  Validity of the Instrumented Push and Release Test to Quantify Postural Responses in Persons With Multiple Sclerosis.

Authors:  Mahmoud El-Gohary; Daniel Peterson; Geetanjali Gera; Fay B Horak; Jessie M Huisinga
Journal:  Arch Phys Med Rehabil       Date:  2017-03-06       Impact factor: 3.966

3.  Myelitis in systemic lupus erythematosus: clinical features, immunological profile and magnetic resonance imaging of five cases.

Authors:  Javier Pablo Hryb; Edson Chiganer; Edgar Carnero Contentti; José Luis Di Pace; Carmen Lessa; Mónica Beatriz Perassolo
Journal:  Spinal Cord Ser Cases       Date:  2016-07-07

4.  Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.

Authors:  Mohamed Boucekine; Anderson Loundou; Karine Baumstarck; Patricia Minaya-Flores; Jean Pelletier; Badih Ghattas; Pascal Auquier
Journal:  BMC Med Res Methodol       Date:  2013-02-15       Impact factor: 4.615

5.  Relevance of quality of life assessment for multiple sclerosis patients with memory impairment.

Authors:  Karine Baumstarck; Françoise Reuter; Mohamed Boucekine; Valérie Aghababian; Irina Klemina; Anderson Loundou; Jean Pelletier; Pascal Auquier
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

6.  Cognitive function and quality of life in multiple sclerosis patients: a cross-sectional study.

Authors:  Karine Baumstarck-Barrau; Marie-Claude Simeoni; Françoise Reuter; Irina Klemina; Valérie Aghababian; Jean Pelletier; Pascal Auquier
Journal:  BMC Neurol       Date:  2011-02-02       Impact factor: 2.474

7.  Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study.

Authors:  Karine Baumstarck; Jean Pelletier; Valérie Aghababian; Françoise Reuter; Irina Klemina; Julie Berbis; Anderson Loundou; Pascal Auquier
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

8.  Validation of the spanish version of the Multiple Sclerosis International Quality of Life (Musiqol) questionnaire.

Authors:  Oscar Fernández; Victoria Fernández; Karine Baumstarck-Barrau; Luis Muñoz; Maria del Mar Gonzalez Alvarez; José Carlos Arrabal; Antonio León; Ana Alonso; Jose Carlos López-Madrona; Rafael Bustamante; Gloria Luque; Miguel Guerrero; Elisabetta Verdun di Cantogno; Pascal Auquier
Journal:  BMC Neurol       Date:  2011-10-18       Impact factor: 2.474

9.  Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials.

Authors:  Rotem Orbach; Zhenming Zhao; Yong-Cheng Wang; Gilmore O'Neill; Diego Cadavid
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  Gray matter blood-brain barrier water exchange dynamics are reduced in progressive multiple sclerosis.

Authors:  Ian J Tagge; Valerie C Anderson; Charles S Springer; Manoj K Sammi; Dennis N Bourdette; Rebecca I Spain; William D Rooney
Journal:  J Neuroimaging       Date:  2021-08-06       Impact factor: 2.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.